Clinical Pathway for Monthly Pulse Intravenous Cyclophosphamide Therapy for Lupus Nephritis

E-ISSN： 2055-2335|42|4|278-282

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.42, Iss.4, 2012-12, pp. : 278-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MMF surpasses cyclophosphamide in lupus nephritis

Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials

By Liu Lin-Lin

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1521-1533

Adis International

Access to resources Recommend Favorite

Low- vs high-dose cyclophosphamide in lupus nephritis

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Use of cyclophosphamide and other immunosuppressive drugs in the treatment of patients with lupus nephritis

By Brugos B. Sebestyen L. Tarr T. Vincze Z.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 6, 2014-06 ,pp. : 442-444

Govi-Verlag

Access to resources Recommend Favorite

Options for sequential therapy in proliferative lupus nephritis

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite